Pihlajalinna Oyj
Market Cap
€331.8m
Last Updated
2020/06/02 00:11 UTC
Data Sources
Company Financials +
Executive Summary
Pihlajalinna Oyj provides social and healthcare services for private persons, businesses, insurance companies, municipalities, and hospital districts in Finland.
Rewards
Risk Analysis
Snowflake Analysis
Moderate growth potential with mediocre balance sheet.
Share Price & News
How has Pihlajalinna Oyj's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PIHLIS has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-0.7%
PIHLIS
1.8%
FI Healthcare
4.6%
FI Market
1 Year Return
33.6%
PIHLIS
4.2%
FI Healthcare
3.9%
FI Market
Return vs Industry: PIHLIS exceeded the Finnish Healthcare industry which returned 4.2% over the past year.
Return vs Market: PIHLIS exceeded the Finnish Market which returned 3.9% over the past year.
Shareholder returns
| PIHLIS | Industry | Market | |
|---|---|---|---|
| 7 Day | -0.7% | 1.8% | 4.6% |
| 30 Day | -1.3% | 6.4% | 7.3% |
| 90 Day | -3.2% | -1.1% | -0.4% |
| 1 Year | 33.6%33.6% | 4.9%4.2% | 7.3%3.9% |
| 3 Year | -14.8%-16.7% | -18.8%-21.8% | 7.4%-3.7% |
| 5 Year | 17.8%14.1% | 1.5%-4.1% | 36.4%12.2% |
Price Volatility Vs. Market
How volatile is Pihlajalinna Oyj's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 year ago | Simply Wall St
Pihlajalinna Oyj (HEL:PIHLIS) Delivered A Weaker ROE Than Its Industry1 year ago | Simply Wall St
What Should Investors Know About Pihlajalinna Oyj's (HEL:PIHLIS) Return On Capital?1 year ago | Simply Wall St
Pihlajalinna Oyj (HEL:PIHLIS): Did It Outperform The Industry?Valuation
Is Pihlajalinna Oyj undervalued compared to its fair value and its price relative to the market?
19.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PIHLIS (€14.7) is trading below our estimate of fair value (€18.16)
Significantly Below Fair Value: PIHLIS is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: PIHLIS is poor value based on its PE Ratio (101.8x) compared to the Healthcare industry average (20.5x).
PE vs Market: PIHLIS is poor value based on its PE Ratio (101.8x) compared to the Finnish market (19.6x).
Price to Earnings Growth Ratio
PEG Ratio: PIHLIS is poor value based on its PEG Ratio (2.8x)
Price to Book Ratio
PB vs Industry: PIHLIS is overvalued based on its PB Ratio (3.2x) compared to the XE Healthcare industry average (1.8x).
Next Steps
Future Growth
How is Pihlajalinna Oyj forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
36.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PIHLIS's forecast earnings growth (36% per year) is above the savings rate (0.4%).
Earnings vs Market: PIHLIS's earnings (36% per year) are forecast to grow faster than the Finnish market (14.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PIHLIS's revenue (4.2% per year) is forecast to grow slower than the Finnish market (5.9% per year).
High Growth Revenue: PIHLIS's revenue (4.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PIHLIS's Return on Equity is forecast to be low in 3 years time (13.9%).
Next Steps
Past Performance
How has Pihlajalinna Oyj performed over the past 5 years?
10.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PIHLIS has a large one-off loss of €6.6M impacting its March 31 2020 financial results.
Growing Profit Margin: PIHLIS's current net profit margins (0.6%) are lower than last year (1.2%).
Past Earnings Growth Analysis
Earnings Trend: PIHLIS's earnings have grown by 10.2% per year over the past 5 years.
Accelerating Growth: PIHLIS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PIHLIS had negative earnings growth (-47.1%) over the past year, making it difficult to compare to the Healthcare industry average (-2%).
Return on Equity
High ROE: PIHLIS's Return on Equity (3.8%) is considered low.
Next Steps
Financial Health
How is Pihlajalinna Oyj's financial position?
Financial Position Analysis
Short Term Liabilities: PIHLIS's short term assets (€72.5M) do not cover its short term liabilities (€120.6M).
Long Term Liabilities: PIHLIS's short term assets (€72.5M) do not cover its long term liabilities (€206.9M).
Debt to Equity History and Analysis
Debt Level: PIHLIS's debt to equity ratio (96.1%) is considered high.
Reducing Debt: PIHLIS's debt to equity ratio has reduced from 580.4% to 96.1% over the past 5 years.
Debt Coverage: PIHLIS's debt is well covered by operating cash flow (52.9%).
Interest Coverage: PIHLIS's interest payments on its debt are well covered by EBIT (4.2x coverage).
Balance Sheet
Next Steps
Dividend
What is Pihlajalinna Oyj's current dividend yield, its reliability and sustainability?
0.73%
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PIHLIS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PIHLIS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PIHLIS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PIHLIS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: PIHLIS is not paying a notable dividend for the Finnish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of PIHLIS's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.3yrs
Average management tenure
CEO
Joni Raimo Aaltonen (49yo)
2.5yrs
Tenure
€284,725
Compensation
Mr. Joni Raimo Mikael Aaltonen has been Chief Executive Officer of Pihlajalinna Oyj since December 11, 2017 and has been its Chairman of the Management Team since August 15, 2019. He was Director of VMP Oy ...
CEO Compensation Analysis
Compensation vs Market: Joni Raimo's total compensation ($USD316.82K) is below average for companies of similar size in the Finnish market ($USD561.49K).
Compensation vs Earnings: Joni Raimo's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Management Team | 2.5yrs | €284.73k | 0.36% €1.2m | |
| Chief Financial Officer | 0.83yr | no data | 0.046% €153.7k | |
| Group COO and CEO of Jämsän Terveys Oy & Jokilaakson Terveys Oy | 0.83yr | no data | 0.027% €88.2k | |
| Chief Business Development Officer & Chief Information Officer | no data | no data | 0.052% €172.0k | |
| Head of Communications & IR | 1.42yrs | no data | no data | |
| Chief Legal Officer | 1.5yrs | no data | 0.018% €58.8k | |
| Chief People & Culture Officer | 1.08yrs | no data | 0.0045% €14.8k |
1.3yrs
Average Tenure
49.5yo
Average Age
Experienced Management: PIHLIS's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 4.42yrs | €34.50k | no data | |
| Independent Vice-Chairman | 1.17yrs | €42.50k | 3.12% €10.3m | |
| Independent Director | 1.17yrs | €26.50k | no data | |
| Independent Director | 1.17yrs | €26.50k | no data | |
| Chairman of the Board | 3.83yrs | €260.00k | no data | |
| Independent Director | 2.17yrs | €31.50k | no data | |
| Independent Director | 1.17yrs | €26.50k | no data |
1.2yrs
Average Tenure
56yo
Average Age
Experienced Board: PIHLIS's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Pihlajalinna Oyj's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Pihlajalinna Oyj
- Ticker: PIHLIS
- Exchange: HLSE
- Founded: 2001
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: €331.819m
- Shares outstanding: 22.57m
- Website: https://www.pihlajalinna.fi
Number of Employees
Location
- Pihlajalinna Oyj
- KehrAesaari B
- Tampere
- Pirkanmaa
- 33200
- Finland
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| PIHLIS | HLSE (OMX Nordic Exchange Helsinki) | Yes | Share Capital | FI | EUR | Jun 2015 |
| PIHLIh | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Share Capital | GB | EUR | Jun 2015 |
| 0R8H | LSE (London Stock Exchange) | Yes | Share Capital | GB | EUR | Jun 2015 |
| 38P | DB (Deutsche Boerse AG) | Yes | Share Capital | DE | EUR | Jun 2015 |
| PIHL.F | OTCPK (Pink Sheets LLC) | Yes | Share Capital | US | USD | Jun 2015 |
Biography
Pihlajalinna Oyj provides social and healthcare services for private persons, businesses, insurance companies, municipalities, and hospital districts in Finland. It offers emergency and on-call, occupational healthcare, dental care, social and healthcare outsourcing, health care outsourcing, responsible doctor, remote consultation, imaging, and staffing services, as well as housing services for the elderly; and primary and specialized care services, which include orthopedics and surgery, internal medicine, neurology, cardiology, geriatrics, gynecology, psychiatry, radiology, and general medicine specialties. The company also operates fitness and reception centers; and books appointment with general practitioners and specialists. Pihlajalinna Oyj was founded in 2001 and is headquartered in Tampere, Finland.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/06/02 00:11 |
| End of Day Share Price | 2020/06/01 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.